Wright State University

CORE Scholar
Browse all Theses and Dissertations

Theses and Dissertations

2016

Theoretical Estimation of pKa's of Pyrimidines and Related
Heterocycles
Rachael Ann Wessner
Wright State University

Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all
Part of the Chemistry Commons

Repository Citation
Wessner, Rachael Ann, "Theoretical Estimation of pKa's of Pyrimidines and Related Heterocycles" (2016).

Browse all Theses and Dissertations. 1543.
https://corescholar.libraries.wright.edu/etd_all/1543

This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has
been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE
Scholar. For more information, please contact library-corescholar@wright.edu.

Theoretical Estimation of pKa’s of
Pyrimidines and Related Heterocycles

A thesis submitted in partial fulfillment
of the requirements for the degree of
Master in Science

By

Rachael Ann Wessner
B.S., Northern Kentucky University, 2014

2016
Wright State University

Wright State University
Graduate School
June 1, 2016

I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY
SUPERVISION BY Rachael Ann Wessner ENTITLED Theoretical Estimation of pKa’s of Pyrimidines
and Related Heterocycles BE ACCEPTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF MASTER of SCIENCE.

____________________
Paul G. Seybold, Ph.D.
Thesis Director
________________________
David A. Grossie, Ph.D.
Department Chair
Committee on
Final Examination
________________________
Paul G. Seybold, Ph.D.

________________________
Eric Fossum, Ph.D.

________________________
David A. Dolson, Ph.D.

________________________
Robert E. W Fyffe, Ph.D.
Vice President for Research and
Dean of the Graduate School

Abstract

Wessner, Rachael Ann. MS., Department of Chemistry, Wright State University, 2016.
Theoretical Estimation of pKa’s of Pyrimidines and Related Heterocycles.
Pyrimidines and related heterocycles are an important class of compounds with a wide
variety of applications. As a result, there is great interest in the chemical properties of these
compounds, specifically their pKa’s. Despite the importance of these compounds their reported
pKa’s are often only approximations or are completely absent from literature. Experimentally
measuring pKa’s can be challenging, especially if the pKa is below zero. Alternatively, pKa’s can
be estimated computationally using a Quantitative Structure-Activity Relationship (QSAR).
However, most of the compounds included in this study exist as two or more forms that arise
from tautomerism. Tautomerism complicates the estimation of pKa’s because proton transfers
result in a rearrangement of electron density that alters chemical behavior. As a result, pKa’s are
unique to each tautomeric species. This research identifies the most stable tautomer associated
with each of the compounds included in this study. From here QSAR models have been
constructed using a variety of molecular descriptors. The resulting QSAR models are then used
to estimate the pKa’s of compounds for which there are currently no literature values.
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Chapter 1
An Introduction to Pyrimidines and Related Heterocycles

1.1 This research project
This study aims to estimate the pKa’s of important pyrimidines and related heterocycles using
quantum chemical methods. Chapter 1 introduces the compounds selected for this study and
details their biochemical roles and applications. Most of these compounds can exist in a number
of tautomeric forms, making it important to determine which forms prevail in both vacuum and
aqueous solution. Accordingly, Chapters 2 and 3 chronicle the investigation of tautomer
stabilities of uracils and cytosines, respectively.
Chapter 4 describes the estimation of pKa’s for these compounds using a Quantitative
Structure-Activity Relationship (QSAR) approach.1-3 This approach employs examination of a
variety of quantum chemical descriptors for their correlation with experimental pKa’s. The
change in energy ΔE between the parent and dissociated forms of the compounds is selected as
the best quantum chemical descriptor for estimating the pKa’s and used for this purpose.
Previously unreported pKa’s are then estimated using this descriptor. Results obtained from the
vacuum and SM8-water solvent model4 in the computational program Spartan’10 (Wavefunction, Inc., Irvine, CA) are compared with experimental data in order to establish the merits
of this method.
Pyrimidines form an important class of nitrogen-containing monocyclic aromatic
compounds. Many pyrimidines are of interest in molecular genetics, neurological research,
pharmaceutical development and other areas. However, despite their widespread applicability,
the pKa’s of many pyrimidines and related compounds are not available. Determining accurate
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dissociation constants is important because it allows the most stable chemical species of a
compound at a particular pH to be identified.
The following section briefly discusses the quantum chemical methods employed, and
Section 1.3 discusses the solvent model. Section 1.4 reviews the roles and applications of the
thirty one pyrimidines and related heterocyclic compounds examined in this study.

1.2 An introduction to quantum chemical methods
There are a variety of computational methods available, each presenting strengths and
weaknesses. Semi-empirical methods are computationally inexpensive, but they are generally not
suited for calculations that require high accuracy. In some cases semi-empirical methods can be
used as a preface to more advanced calculations in order to decrease computational time. The
Hartree-Fock method consistently overestimates the molecular energy because it does not
account for electron correlation. Moller-Plesset5,6 perturbation theory is similar to the HartreeFock method, but treats electron correlation energy as a perturbation. Configuration interaction is
a variational method that is capable of accounting for electron correlation, but it is generally only
applied to small molecules because it is computationally expensive. Density functional
Theory7,8,9 (DFT) is different from other quantum chemical methods in that it works with the
electronic probability distribution rather than the wave function itself. It is advantageous because
it accounts for electron correlation while remaining relatively computationally inexpensive.
Coupled Cluster10 calculations are currently considered the gold-standard of quantum chemical
methods, but are extremely computationally demanding.
In the computations used in the present work rough starting geometries were obtained using
the semi-empirical method RM1.11 Density functional theory at the B3LYP/6-31+G** level was
selected to further optimize the equilibrium geometries because it generally yields values
2

comparable to experimental data.12 The B3LYP functional is a widely-used functional within
DFT theory. The 6-31+G** basis set approximates each inner-shell Slater-type orbital with six
Gaussian functions.13 Each valence atomic orbital is expanded as an inner and an outer Slatertype orbital, which in turn are approximated with 3 and 1 Gaussian functions, respectively.13
Diffuse functions (+) are added to each of the heavy atoms to account for dispersion of electron
clouds, particularly in anions, and polarization functions (**) are added to both the heavy and
light atoms to correct for ionic character.13

1.3 An introduction to solvent models
A solvent model was required because the experimentally determined pKa’s considered here
were measured in aqueous solution. The use of a solvent model is expected to improve the
correlation between quantum chemical descriptors and experimental pKa’s by accounting for
solvation energy and other solvent effects. Accurate solvent models must include long distance
polarization effects, short distance polarization effects and short distance electrostatic
interactions such as hydrogen bonding.4 There are two main types of solvent models, referred to
as implicit and explicit. Explicit solvent models account for solvent-solute interactions by
incorporating discrete solvent molecules into the calculation.2, 14 This method is disadvantageous
because it is very computationally demanding, while still failing to completely replicate all
properties of aqueous solvation. Implicit solvent models are much less computationally
demanding but lack the ability to directly account for discrete solvent-solute interactions. Instead,
implicit solvent models include both macroscopic properties such as dielectric constant and bulk
surface tension as well as microscopic properties such as polarizability and effective solvent
radius.2 The SM8 solvent model4 (an implicit solvent model) was selected for this study because
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it has been parametrized to reproduce experimental energies and has shown reasonable accuracy
in previous studies.15-16

1.4 Biochemical roles and applications of pyrimidines and related heterocycles
This section reviews some of the biochemical roles and applications of pyrimidines and
related heterocycles, and highlights the significant differences in chemical properties that can
arise from small changes in chemical structure. These compounds have diverse medicinal uses
and are found abundantly in nature. As a result, heterocyclic chemistry is an important area of
study. Figure 1 shows the compounds that will be included in the pKa study, although, this
chapter will discuss additional important derivatives.

4

Figure 1: Pyrimidines and related heterocycles examined in this study.
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■ Nucleobases and the origin of life
The pyrimidine moiety is most notably found in the nucleobases cytosine, thymine and
uracil, which are key components of nucleic acids.17 The role of nucleobases in the origin of life
has been heavily investigated and these compounds play a central role in modern genetics. Many
studies have attempted to synthesize pyrimidine nucleobases and their complimentary purines
under prebiotic conditions, but their presence on prebiotic earth is still debated.18-19
In order for RNA to have contributed to the origin of life, as many theories suggest, the
nucleobases and their complimentary purines must have been readily available on prebiotic
earth.18 Cytosine is believed to have been synthesized from cyanoacetlyene and cyanate, and
uracil can be formed if cytosine undergoes aqueous hydrolysis under mild conditions.18 Miller et
al. demonstrated that the precursors required to synthesize cytosine and uracil are formed in
abundance from the action of electric discharge on a gas mixture containing methane, ammonia
and water.20 Although prebiotic earth did contain the reagents necessary to synthesize cytosine
and uracil the conditions would have been far too extreme for spontaneous synthesis to occur,19
and if cytosine was formed it would have most likely been consumed by deamination or other
nucleophilic reactions.18
However, small amounts of pyrimidines were extracted from the Murchison meteorite,
which has led some scientists to conclude that a synthetic route must have been possible under
prebiotic conditions.19 Robertson et al. proposed that cytosine could have been synthesized from
cyanoaldehyde (formed from the hydrolysis of cyanoacetylene) and high concentrations of urea
(released from lagoons).19
Studies have also examined the prebiotic synthesis of purines to understand their
relationship with early nucleobases. Guanine, which base pairs with cytosine, is the only purine
6

that has not been successfully synthesized. The inability to synthesize guanine under prebiotic
conditions led to an investigation of Watson-Crick base pairing of cytosine with its structural
isomer isocytosine.21 Accordingly, it has been theorized that isocytosine may have paired with
cytosine in place of guanine in early nucleic acids.21

■ Bioactive pyrimidines and related heterocycles
Many pyrimidines and related heterocycles are biologically active compounds that are
commonly used as constituents in pharmaceutical synthesis. Pyrimidine is easily modified to
synthesize many diverse derivatives that are capable of targeting a wide-variety of
biochemical pathways.22 For example, pyrimidine derivatives are known to exhibit
many pharmacological properties including anticonvulsant, antibacterial, antiviral, antifungal,
and antitumor activities.22 As a result, many drugs in this class have been listed on the World
Health Organization’s list of essential medicines.
Barbiturates (derived from barbituric acid) are a widely-used class of drugs that act on the
central nervous system. These drugs have a wide range of activities
including sedative, anesthetic and antiepileptic activities.17
Phenobarbital is a common anti-seizure medication that expresses
sedative properties. Pernocton was the first barbiturate to be used intravenously
in anesthesia.23 Other barbiturates have been successful in the treatment of schizophrenia and
anxiety.23 Barbiturates have also found use in pain management, but were
eventually replaced by benzodiazepines because they carried a high risk of
dependence and death by overdose.23 Some barbiturates, such as pentobarbital, were so toxic
that they were used in executions throughout the United States.23
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Related heterocycles such as piperazine and isoxazole have found use in the treatment of
Alzheimer’s disease. Alzheimer’s disease is estimated to affect approximately 26 million people
worldwide and the search for a cure has proven difficult.24 A few compounds
have been shown to help manage neurodegeneration and cognitive decline
associated with Alzheimer’s disease. A piperazine containing drug known as
4-(2-hydroxyethyl)-1-piperazinepropanesulphonic acid (EPPS) has recently
been shown to disaggregate toxic oligomers and plaques that have been linked to the early
manifestation of Alzheimer’s disease.25 The transition of amyloid-beta monomers into toxic
oligomers and plaques often precedes the development of clinical symptoms which intensifies
the need for an agent capable of reversing their formation.25 Isoxazole containing
drugs have also shown promise in the treatment of treatment of Alzheimer’s disease
by inhibiting acetylcholinesterase.26 Acetylcholinesterase is the enzyme responsible for
terminating the transmission of nerve impulses in cholinergic synapses.26 The treatment of
Alzheimer’s disease currently focuses upon normalizing acetylcholine levels, so the ability to
inhibit acetylcholinesterase might be a viable way to manage neurological symptoms.26
As previously mentioned, many pyrimidine based drugs are antimetabolites, because they
are structurally similar to the endogenous substrates they antagonize.27 Antimetabolites can
generally be categorized as nucleobase analogues, nucleoside
analogues, nucleotide analogues and antifolates. 5-fluorouracil
and thiouracil are examples of early pyrimidine derivatives that
showed anticancer properties.27 Other common examples include trimethoprim, sulfadiazine and
bleomycins which are used in chemotherapy.17 Succinimide has been shown to express
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antimicrobial, antitumor and anti-inflammatory properties.28 Several derivatives of succinimide
have recently been placed in clinical trials as candidates in the treatment of melanoma.28
Some pyrimidine derivatives are also antibiotics. For example, aminoglycoside
antibiotics like phleomycin and bleomycin are wide-spectrum antibiotics that contain the
pyrimidine moiety.27 Bacimethrin is a pyrimidine derivative that is used to treat staphylococcal
infections.27 The first sulfonamide antibacterial agent was a pyridine derivative known as
sulfapyridine.17 Other sulfa drugs such as sulfadiazine and sulfadimidine are often used to treat
urinary tract infections and cerebrospinal meningitis.27 Sulfa drugs are very important for people
who are allergic to penicillin and for HIV positive patients that are prone to
infections.27 The pyrimidine moiety is also found in a number of drugs that
are used to treat hepatitis C, AIDS/HIV and herpes. Sovaldi, Harvoni and
Dasabuvir are well-known antiviral agents used to treat hepatitis C.
Azidothymidine and zidovudine are antiretroviral medications that are used to prevent
HIV/AIDS.
Other pyrimidine derivatives are known antifungals and antihelmintics. Flucytosine is a
nucleoside antifungal that is used to treat systemic infections caused by exposure to
Candida and Cryptococcus fungi.27 Pyrantel pamoate is used to rid hosts of
pinworms and roundworms by causing spastic paralysis to the worms.27 The
pyridazine derivative maleic hydrazide is used as both a an anthelmintic and a herbicide.17

■ Pyrimidines and related heterocycles in nature
Pyrimidine rings and related heterocycles are also found abundantly in nature, and serve a
variety of purposes. Pyrimidine-like rings are found most notably in the vitamin B complex,
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chlorophyll, plant pigments, alkaloids, alarm pheromones in ants,17 amino acids and proteins,
enzymes and DNA.26 Imidazole rings are found in the histidine residues of many
proteins and enzymes and can act as natural buffers.17 Imidazole can also form
complexes with many metal ions, perhaps the best-known, example being
hemoglobin.17 Hemoglobin is a Fe (II)-complex of heme with the imidazole moiety of the amino
acid histidine contained in the protein globin.17
In nature, pyrrole rings are most commonly found as bilirubinoids (linear tetrapyrroles),
porphyrins and corrins (cyclic tetrapyrroles).17 Bilirubinoids are formed
when porphyrins are oxidized and commonly occur in vertebrates,
invertebrates and algae.17 Porphyrins are composed of four pyrrole units
connected by methine bridges at the α-carbons.17 Many key biomolecules
such as hemoglobin and chlorophyll employ porphyrin-like moieties to chelate metal ions.17
1-methypiperazine is a small heterocyclic compound found in variable concentrations on
human skin.29 It is naturally produced in some individuals or it can be generated by bacteria that
live on the skin.29 The presence of 1-methylpiperazine prevents mosquitoes from detecting the
presence of the individual,29 and may explain why some people are more prone to mosquito bites
than others.29
Piperidine is found in the pituitary, pineal and adrenal glands of mammals.30 It is
responsible for the release of acetylcholine, serotonin and pituitary hormones, which has led to
its investigation as a modulator of the neuroendocrine system.30 Piperidine
alkaloids are commonly found in plants such as pomegranates and palm tree
seeds.17 The piperidine alkaloid coniine is the toxin found in poison
hemlock.17 Isoxazoles have also been isolated from many natural

10

sources including insecticides, plant growth regulators and pigments.26 Isoxazole has also been
identified as the active constituent in the psychotropic fly agaric mushroom.26 Paraquat and
diquat are pyridine derivatives that show biological activity as herbicides. The herbicide
difenzoquat and the insecticide dimetilan are also biologically active derivatives of pyrazole.17
A similar heterocycle is found in creatinine, which is a small
molecule related to renal function. Creatinine is a produced when high
energy creatine phosphate is decomposed in muscle tissue.31 Healthy
renal function is characterized by a constant expulsion of creatinine from the body by the
kidneys.31 Accordingly, renal function is often assessed by measuring the level of creatinine in
the blood, where an atypical level of creatinine in the blood stream indicates kidney problems.31
5-methylcytosine is another important compound containing the pyrimidine moiety that
has been heavily researched for its role in epigenetics. Epigenetics explains heritable changes in
gene expression that are not the result of changes in DNA sequence. 5methylcytosine is formed when an enzyme in the methyltransferase family
methylates the C5 position of cytosine.32 Most tissues exhibit methylation
patterns that are part of normal regulatory function. However, hypermethylation can result in
silenced genes by inhibiting transcription factors from binding to affected DNA.32 The cause of
atypical methylation is unknown, but it is believed to be linked to life experiences such as
medication, exercise, diet and trauma.32 Atypical methylation has been linked to the onset of a
variety of diseases including Alzheimer’s disease (AD), mental disorders, diabetes, and
autoimmune diseases. For example, researchers discovered unusually high methylation levels in
the entorhinal cortexes (primary site of manifestation in AD) of post mortem cohorts that were
afflicted with AD.24 Another study found that consistent exercise could alter methylation
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patterns, which explains why physical activity has long been prescribed as an effective treatment
for a variety of ailments.33
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Chapter 2
Analysis of Uracil Tautomers

2.1 What are tautomers and why are they important in this study?
Tautomerism (see, for example, Figure 2) refers to the transfer of a proton between two sites
on a compound.34 It is important to recognize that tautomerism is not limited to neutral species;
charged compounds also may exist in several ionic forms as well and these forms can also
display tautomerism. As a simplification, the most stable ionic species can normally be attributed
to protonation or deprotonation of the most stable neutral species. Accordingly, only ionic
species derived from the most stable neutral species normally needs to be examined, which
significantly reduces computational effort.

Figure 2: An example of keto-enol tautomerism in maleimide.

As discussed at greater length in Chapter 4, we define the pKa for dissociation of the
cationic species of a compound to form the neutral species as pKa1, and that for dissociation of
the neutral species to form the anion as pKa2. Consequently, identifying the most stable species
of each type is necessary to correctly identify the dissociation reactions responsible for pKa1 and
pKa2.
Most of the compounds included in this study can exist as two or more tautomeric forms,
both in vacuum and in solution. Dissociation constants and their positions are unique to each
13

tautomeric species because proton transfers result in a rearrangement of electron density that
alters chemical behavior.35 In some cases literature reports fail to identify the tautomeric form
associated with a particular dissociation constant, so care must be taken when assigning
experimental pKa’s to compounds that exist in multiple forms. This chapter aims to identify the
predominant form of each uracil-type species included in this study so that experimentally
measured pKa’s can be accurately assigned. In addition, the physicochemical features that affect
tautomeric stability will be analyzed in order to understand the relationship between tautomerism
and chemical behavior.

2.2 What factors influence the stability of a tautomer?
The stability of a tautomer is dependent upon both structural features and environmental
conditions. Stability is influenced by a number of factors including solute-solvent hydrogen
bonding, medium polarity, and substituents. In the gas phase, i.e., vacuum, the energy Evac of a
compound is often referred to as the intrinsic stability because external factors are absent. The
intrinsic stability of each species can be used to assess the impact of solvation. Solvation energy
(Eq. 1) is defined as the energy change ΔEsolv that arises when a compound is placed in a solvent
yielding Esoln.
ΔEsolv = Esoln – Evac

(1)

The solvation energy ΔEsolv is the result of both Van der Waals and hydrogen bonding
interactions that occur between solute and solvent molecules. In aqueous solution solutes that
exhibit a more heterogeneous charge distribution will normally have a greater solvation energy
because solvent molecules can more readily form strong local electrostatic interactions with
them. In computational studies it is also important to recognize that solvation energy can be
affected by a change in molecular geometry.
14

Often the predominant tautomer is medium dependent as shown in Figure 3. In vacuum
tautomers that exhibit homogeneous charge distributions are normally favored because
sustaining charge differences requires energy. In aqueous solution forms that exhibit
heterogeneous charge distributions can be lower in energy because of the formation of local
associations with solvent molecules. Keto-enol tautomerism is particularly solvent dependent,
largely due to electrostatic interactions. In vacuum or in nonpolar solvents enol forms are
generally favored, but in aqueous environments, particularly under biological conditions, keto
forms are usually preferred.35 In the example in Figure 3 compound B is more stable in vacuum,
but because of a large solvation energy compound A is more stable in solution.

Figure 3: Intrinsic and solvation energies of two tautomeric species.

Substituent-induced alterations in electron density can also influence pKa1 and pKa2
because the pKa depends on the most stable dissociating and dissociated tautomers.35 The most
stable cation (pKa1) is expected to form at the site with the most negative charge in the neutral
species because the positive proton will be held more tightly there, and the most stable anion
(pKa2) is expected to form at the site with the smallest negative charge because the positive
proton will be more readily released. Figure 4 shows a tautomerism of uracil in vacuum and the
relative stabilities of each form. If kf and kr are the forward and reverse reaction rate constants
(Eq. 2), respectively, the equilibrium constant Keq is defined as kf/kr.
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𝒌

𝑲𝒆𝒒 = 𝒌𝒇

(2)

𝒓

0 kJ/mol

74.4 kJ/mol

Figure 4: An example of amine-imine tautomerism in neutral uracil and the relative energies of
each form in vacuum.

The most stable tautomer is characterized by the lowest energy with respect to other
comparable species. Some compounds may exhibit two or more almost equally stable tautomers
in a particular environment. If several stable species are present their population ratios can be
estimated using the Boltzmann distribution law (Eq. 3) where N1 and N2 are the populations of
tautomers 1 and 2 and ΔE is their energy difference.
𝑵𝟐
𝑵𝟏

= 𝒆−𝜟𝑬/𝑹𝑻

(3)

Hybridization plays a key role in the stability of tautomers, particularly in the relative stabilities
of protonated heterocyclic imines and amines. Protonation of a heterocyclic ring imine is almost
always more energetically favored than protonation of a heterocyclic ring amine because it
preserves the aromaticity of the ring. Aromaticity is maintained because the lone pair on a
neutral imine resides in a sigma sp2 orbital in the plane of the ring (Figure 5) and attachment of a
proton here does not destabilize the pi system. The lone pair on a neutral amine resides in a 2pz
orbital perpendicular to the ring and contributes to the pi system. Protonation of this orbital
induces a hybridization change that results in a loss of aromaticity. In some cases compounds
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may act as carbon acids to avoid protonation of the amine, which is a higher-energy
transformation than carbon protonation (Figure 4).

Figure 5: Two possible sites of protonation in pyrimidine showing the hybridization of each
product. The cation on the right is more stable than the cation on the left.
2.3 The importance of uracil and its derivatives
Uracil is a nucleobase found in RNA that exhibits a pKa2 of ~9.42 under physiological
conditions.36 In its canonical form uracil exists as a neutral diketo species that can form a base
pair with adenine. The occurrence of rare uracil tautomers and derivatives in genetic material is
believed to induce mutagenicity, specifically if the chemical modification drastically alters the
pKa of base pairing protons 36 Electron-withdrawing groups typically cause a decrease in pKa,
and electron-donating groups usually raise the pKa.37 In uracil derivatives the pKa’s of N1H and
N3H are heavily dependent on the properties of the substituent bonded to C5.38 The chemical
nature of C5 substituents often affects the pKa2 of N1H and N3H differently, making it difficult to
experimentally establish whether dissociation to the anion occurs at N1H or N3H.38

2.4 Methods
A list of possible neutral tautomers was generated for each of the compounds included in
this study. The energy of each species was calculated in vacuum and in aqueous solution using
the Spartan’10 computational software package (Wavefunction, Inc., Irvine, CA) and the SM8
aqueous solution model. 4 The geometries were initially optimized using the semiempirical
method RM111 and then further optimized using density functional theory at the B3LYP/ 617

31+G** level. The energy of each tautomer was recorded and expressed as a relative energy with
respect to the most stable species of that charge. The energy of each ionic species (associated
with the most stable neutral tautomer) was also calculated and expressed as a relative energy.
These calculations allowed the species responsible for pKa1 and pKa2 to be identified. The natural
charges on the heavy atoms (for the most stable neutral species) were also recorded to assist in
the identification of the dissociating species.

2.5 Results
Uracil and each of its derivatives have three possible positions of protonation (pKa1) denoted
N1, N3 and C5 (see Figure 6 for numbering scheme).

Figure 6: Pyrimidine numbering scheme.
The related compound azauracil has four possible positions of protonation known as N1, N3, C5
and N6. All of the compounds examined in this study can dissociate at either N1 or N3. In each
tautomer figure the lowest-energy form in vacuum is indicated by red font and the lowest-energy
form in water is indicated by blue font. This color scheme is also employed in the natural charge
figures.

■ Uracil
Many experimental and theoretical studies have examined tautomerism in uracil, and the
majority of researchers have agreed that uracil exists primarily as a diketo species. Electron
diffraction studies conducted by Ferenczy et al.39 led to the conclusion that uracil primarily exists
in the diketo form. Feyer et al.40 corroborated this finding through X-ray absorption and resonant
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auger experiments. A theoretical study by Millefiori et al.41 calculated the relative stabilities of
uracil tautomers in vacuum and in aqueous solution using coupled cluster (CCSD, CCSD(T)) and
density functional theory (B97-1 and PBE1PBE functionals) and found that the diketo species is
~53 kJ/mol more stable than other forms.
The results obtained in the present calculations are in agreement with the conclusions
drawn from these studies. A list of the relative B3LYP/6-31+G** energies can be found in Table
1 along with the solvation energies of each species. The structure of each tautomer considered in
this study can be found in Figure 7. Calculations showed that U-1 (diketo species) was ~74
kJ/mol more stable than the other tautomers in vacuum. In aqueous solution the relative energy
of U-1 remained ~70 kJ/mol more favorable despite the large solvation energy of U-4 because its
intrinsic energy is much lower than that of U-4. The electrostatic potential surfaces (see Figure 8)
show that U-4 has a somewhat more heterogeneous charge distribution than U-1, which helps
explain the large solvation energy of U-4 shown in Table 1.

Figure 7: Neutral uracil tautomers.
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U-4
U-1
Figure 8: Comparison of electrostatic potential maps of U-1 and U-4.

The natural charges on the heavy atoms in U-1 are reported in Figure 9. Quantum
chemical calculations show that the natural charge of N1 is less negative than the natural charge
of N3 despite the proximity of the keto groups. Carbon 5 displays a negative charge making it an
ideal position for protonation. Also notice that the charges on the keto oxygens become more
negative in aqueous solution which may be due in part to enhanced contributions from a
zwitterionic resonance form (Figure 10).15

Figure 9: Natural charges on the atoms in U-1.

Figure 10: Zwitterionic contribution to the structure of uracil.

Both vacuum and aqueous solution calculations show that protonation should occur
predominately at C5, which suggests that protonating a carbon is a lower-energy transition than
protonating an amine (Figure 11, Table 1). Uracil has not been previously reported to act as a
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carbon acid, but other compounds, such as pyrrole, are well known to be carbon acids in their
cationic forms.42 Protonation is unlikely to occur at an amine because the resulting cations are
much higher in energy.

Figure 11: Low-energy cationic tautomers of uracil.

Calculations showed that uracil is most likely to dissociate at N1H (Figure 12) in vacuum
because N1- is ~57.7 kJ/mol more stable than N3-. In the neutral diketo species, N1 carries a less
negative natural charge than N3, which supports the conclusion that N1 is the primary site of
dissociation (Figure 9). In aqueous solution a small amount of U--2 (~4 %) is also expected to
form because U--2 has a significantly larger solvation energy (~329 kJ/mol) than U--1 (~279
kJ/mol). The electrostatic potential maps (shown in Figure 13) of U--1 and U--2 show a more
heterogeneous charge distribution of charge in U--2, which is indicative of a greater solvation
energy.
Jang et al. 37 investigated anionic tautomerism in uracil using different quantum chemical
methods and has obtained slightly different results. Initial equilibrium geometries were obtained
using density functional theory (B3LYP/6-31+G*) and then further optimized using a higher
level basis set (cc-pVTZ(-f)++). Vacuum calculations showed that the dissociation of N1H was ~
48-58 kJ/mol more favorable than dissociation of N3H, which is comparable to the results
obtained in the present study. A continuous-solvation approach that involved numerically solving
the Poisson-Boltzmann (PB) equation was used to calculate the ΔGsolv. In contrast to the present
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study, Jang et al. found that dissociation at N3H was ~ 62-68 kJ/mol more favorable than
dissociation of N1H.37 Advanced Chemical Developments (ACD) also cites N3H as the primary
site of dissociation in neutral uracil under physiological conditions. These differences can most
likely be attributed to the differing methods employed by these studies.

Figure 12: Low-energy anionic tautomers of uracil.

U--2
U--1
Figure 13: Electrostatic potential maps of the anionic forms U--1 and U--2.

Table 1: Relative energies and solvation energies of uracil tautomers.
Neutral
U-1
U-2
U-3
U-4
U-5
U-6
Cationic
U+-1
U+-2
U+-3
Anionic
U--1
U--2

Rel. E Vac. kJ/mol
0
74.4
76.7
80.2
81.7
89.4
Rel. E Vac. kJ/mol
0
42.2
61.8
Rel. E Vac. kJ/mol
0
57.7

Sol. Energy kJ/mol
-57.3
-63.7
-77.5
-102.0
-93.6
-88.4
Sol. Energy kJ/mol
-327.6
-304.8
-316.3
Sol. Energy kJ/mol
-279.4
-329.1

Rel. E Aq soln. kJ/mol
0
68.1
56.5
35.5
45.5
58.3
Rel. E Aq soln. kJ/mol
0
61.8
42.2
Rel. E Aq soln. kJ/mol
0
8.0
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■ Azauracil
The structures of the neutral azauracil tautomers considered in this study are shown in
Figure 14. In both vacuum and aqueous solution AZ-1 was the lowest energy neutral tautomer of
azauracil. As seen in Table 2 the other forms were too high in energy to be considered significant
tautomers.

Figure 14: Neutral azauracil tautomers.

The natural charges on the heavy atoms in AZ-1 are reported in Figure 15. In general, the
most stable cation should form at the nitrogen with the greatest negative charge and the most
stable anion should form at the nitrogen with the smallest negative charge. However, results
suggest that in some cases natural charges alone do not accurately predict the propensity of a
group to ionize. Natural charges can be useful in understanding ionization if other factors such as
hybridization are equivalent. Natural charges can also provide insight into the changes in
electronic distribution that occur as a result of solvation. Here again notice that the charges on
the keto oxygens become more negative in aqueous solution and the charges on the amine
nitrogens become slightly less negative.
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Figure 15: Natural charges on the heavy atoms in AZ-1.

In vacuum and in aqueous solution AZ+-1 (Figure 16) was significantly more stable than
the other cationic tautomers because it is the only form that remains semi-aromatic (Table 2).

Figure 16: Low-energy cationic tautomers of azauracil.

In vacuum a mixture of anionic species is expected to form because several low-energy
positions for proton dissociation are available. Based upon the vacuum energies of the anion
tautomers, N1H is expected to be the preferential site of dissociation (~94%), yielding AZ--1 but
smaller quantities (~6%) of AZ--2 are also expected to be present. In aqueous solution
dissociation at N3H becomes more favorable because AZ--2 has a significantly greater solvation
energy than AZ--1. In vacuum the anion that exhibits the most homogeneous charge distribution
is likely to be favored. However, in aqueous solution the anion that exhibits the most
heterogeneous charge distribution should be more stable because solvent molecules can readily
form local electrostatic interactions with local charged regions of the molecule. As a result,
species with the more nonuniform charge distributions are expected to exhibit greater solvation
energies (Figure 17). Molecular electrostatic potential maps (shown in Figure 18) can be used to
illustrate the differences in charge distribution observed in AZ--1 (ΔEsolv ~ -298 kJ/mol) and AZ-24

2 (ΔEsolv ~ -272 kJ/mol). Notice that solvation energies are greater for ionic species than they are
for neutral species because they have an increased capability to form strong associations with
polar solvent (here H2O) molecules.

Figure 17: Low-energy anionic tautomers of azauracil.

AZ--1

AZ--2

Figure 18: Molecular electrostatic potential maps of AZ--1 and AZ--2.
Table 2: Relative energies and solvation energies of azauracil tautomers.
Neutral
AZ-1
AZ-2
AZ-3
AZ-4
AZ-5
AZ-6
Cationic
AZ+-1
AZ+-2
AZ+-3
AZ+-4
Anionic
AZ--1
AZ--2

Rel. E Vac. kJ/mol
0
49.3
76.3
82.8
111.1
149.3
Rel. E Vac. kJ/mol
0
57.1
71.8
79.0
Rel. E Vac. kJ/mol
0
6.7

Sol. Energy kJ/mol
-42.6
-66.8
-59.4
-64.3
-98.2
-90.1
Sol. Energy kJ/mol
-340.2
-309.8
-313.5
-303.5
Sol. Energy kJ/mol
-272.4
-298.2

Rel. E Aq soln. kJ/mol
0
25.8
59.5
61.1
55.4
101.7
Rel. E Aq soln. kJ/mol
0
87.5
98.5
115.6
Rel. E Aq soln. kJ/mol
19.1
0
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■ 5-Bromouracil
Most literature reports indicate that 5-bromouracil exists primarily as a diketo species.
Hanus et al.43 used Coupled Cluster (cc-pVTZ) calculations to investigate the relative stabilities
of 5-bromouracil tautomers in vacuum and using a bulk water model and reported that the
neutral diketo species was exclusively present. Hanus et al. also refuted the previous report by
Hu et al. 44 that suggested Hartree-Fock (STO-3G) calculations carried out in a bulk water model
predicted favorability of enolic species. The study by Hu et al. most likely indicated the presence
of enolic species because its lower level of theory did not account for electron correlation.
The 5-bromouracil tautomers investigated in this study are shown in Figure 19. Table 3
shows the relative B3LYP/6-31+G** energies of each tautomer in vacuum and in aqueous
solution, as well as the solvation energy associated with each species. As seen in uracil, the
neutral diketo species was significantly more stable than enolic species in both vacuum and
aqueous solution. Solvation did not appear to have a significant effect on the relative energies of
the tautomers as the order of stability remained largely the same. The results of these calculations
indicate that the presence of enolic tautomers is unlikely given their much higher energies.

Figure 19: Neutral 5-bromouracil tautomers.
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The natural charges on the heavy atoms in BrU-1 are reported in Figure 20. Notice that
the natural charge on N1 is less negative than the natural charge on N3. As seen in uracil, C5
carries a significantly negative charge that makes it a good position for protonation. However,
the natural charge on C5 in 5-bromouracil is less negative than that in uracil, possibly because the
bromine donates electron density to the π-system.

Figure 20: Natural charges on the heavy atoms in BrU-1.

Both vacuum and aqueous solution calculations indicated that protonation is most likely
to occur at C5 (Figure 21). Protonation occurred predominantly at C5, despite the addition of
bromine, which further supports that protonating a carbon is less energy-requiring than
protonating an amine. Literature held no reports of carbon acid behavior in 5-bromouracil, which
may be due to the exceptionally low pKa1. Often it is quite difficult to experimentally measure
pKa’s that are in the negative region.

Figure 21: Low-energy cationic tautomers of 5-bromouracil.

In vacuum and in aqueous solution calculations suggest that dissociation is most likely to
occur at N1H (Figure 22). In aqueous solution N3H is expected to dissociate in small quantities
27

(~3%). In contrast, Privat and Sowers have suggested that dissociation of N3H should be
enhanced, with respect to uracil, because the bromine can stabilize N3- through induction.36 Yet
according to quantum chemical calculations N1 has a slightly less negative charge than N3 which
should heighten dissociation because the positive proton will be more readily released (Figure
20).

Figure 22: Low-energy anionic tautomers of 5-bromouracil.

Table 3: Relative energies and solvation energies of 5-bromouracil tautomers.
Neutral
BrU-1
BrU-2
BrU-3
BrU-4
BrU-5
BrU-6
Cationic
BrU+-1
BrU+-2
BrU+-3
Anionic
BrU--1
BrU--2

Rel. E Vac. kJ/mol
0
40.4
48.2
50.9
102.1
120.4
Rel. E Vac. kJ/mol
0
44.8
55.0
Rel. E Vac. kJ/mol
0
57.4

Sol. Energy kJ/mol
-54.8
-58.1
-61.3
-75.7
-80.4
-119.4
Sol. Energy kJ/mol
-295.1
-308.1
-284.9
Sol. Energy kJ/mol
-267.9
-316.7

Rel. E Aq soln. kJ/mol
0
37.0
41.6
30.0
76.5
55.7
Rel. E Aq soln. kJ/mol
0
42.1
55.0
Rel. E Aq soln. kJ/mol
0
8.7

■ 5-Chlorouracil
Many studies have investigated tautomerism in 5-chlorouracil, using a variety of different
experimental and computational techniques. A theoretical study by Lukmanov et al.45 used
composite G3MP2B3 and density functional theory (TPSS) methods to examine tautomerism in
5-chlorouracil. Results indicated that the diketo species is the most favorable form of 528

chlorouracil in both vacuum and an explicit (first solvation shell modeled with five H20
molecules) implicit solvent model. However, florescence experiments by Suwaiyan et al. 46 have
found evidence that enolic species of 5-chlorouracil may be present in minute concentrations at
room temperature.
Figure 23 displays the neutral tautomers of 5-chlorouracil that were examined in this
study. The relative energies of the tautomers and their associated solvation energies can be found
in Table 4. Calculations showed that the diketo species (ClU-1) was significantly lower in energy
than the other tautomers in both vacuum and aqueous solution. The enolic tautomers of 5chlorouracil are ~35 kJ/mol higher in energy than the diketo species which suggests that they are
unlikely to contribute significantly to the neutral population.

Figure 23: Neutral 5-chlorouracil tautomers.

The natural charges on the heavy atoms in ClU-1 are reported in Figure 24. As for the
previous compounds, the natural charge at N1 is less negative than the natural charge at N3. As
seen in uracil, C5 carries a significant negative charge that makes it a good position for
protonation. The chlorine at C5 is significantly less positive than the bromine in 5-bromouracil
which indicates that chlorine is a much more electronegative than is bromine and it is less willing
to share its outer shell electrons than bromine. Also notice that the natural charges on the keto
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oxygens become more negative in aqueous solution because solute-solvent interactions provide
additional support for charge delocalization.

Figure 24: Natural charges on the heavy atoms in ClU-1.

Chlorinating C5 produced results comparable to those observed in 5-bromouracil which is
not surprising given their almost indistinguishable pKa2’s. As seen in 5-bromouracil, C5 was the
preferential site of protonation in 5-chlorouracil. The energy required to protonate a carbon
remained lower than that required to protonate an amine despite halogenation. The cationic
population was dominated by ClU+-1 as shown in Figure 25. Again, no literature reports of
carbon acid behavior in 5-chlorouracil were found.

Figure 25: Low-energy cationic tautomers of 5-chlorouracil.

In vacuum N1H is expected to be the primary site of dissociation (Figure 26), because
ClU--1 is considerably lower in energy than ClU--2. As observed in 5-bromouracil, N1 exhibits a
slightly less negative charge than N3 which supports the preference for dissociation at this
position (Figure 24). In aqueous solution a mixture of anions was predicted, although ClU--1 still
accounted for ~98% of the anionic population. It is worth noting that ClU--2 has a substantially
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larger solvation energy than ClU--1 because it exhibits a much more heterogenious distribution of
charge (Table 4). As previously pointed out, a large solvation energy can drastically increase the
stability of a compound in aqueous solution. These results suggest that chlorinating C5 resulted
in decreased dissociation of N3 with respect to uracil. However, Privat and Sowers have
suggested that chlorinating C5 should result in enhanced ionization of the N3 proton.36

Figure 26: Low-energy anionic tautomers of 6-chlorouracil.

Table 4: Relative energies and solvation energies of 5-chlorouracil tautomers.
Neutral
ClU-1
ClU-2
ClU-3
ClU-4
ClU-5
ClU-6
Cationic
ClU+-1
ClU+-2
ClU+-3
Anionic
ClU--1
ClU--2

Rel. E Vac. kJ/mol
0
39.9
48.0
51.3
84.9
102.8
Rel. E Vac. kJ/mol
0
31.3
40.1
Rel. E Vac. kJ/mol
0
57.2

Sol. Energy kJ/mol
-55.2
-57.7
-58.4
-74.2
-54.6
-78.5
Sol. Energy kJ/mol
-312.9
-295.8
-320.2
Sol. Energy kJ/mol
-263.7
-317.1

Rel. E Aq soln. kJ/mol
0
37.3
44.8
32.3
85.4
79.5
Rel. E Aq soln. kJ/mol
0
48.4
32.8
Rel. E Aq soln. kJ/mol
0
3.9

■ 5-Fluorouracil
The majority of research has concluded that 5-fluorouracil exists primarily as a diketo
species. Munoz et al.47 have theoretically investigated tautomerism in 5-fluorouracil in vacuum
and with explicit solvent models (20 and 30 H2O molecules) using B3LYP/6-31+G**(3df, pd),
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B3LYP/DGDZVP, and MP2/6-31G**. Their study indicated that the diketo species of 5fluorouracil is the most stable tautomer both vacuum and with an explicit solvent model. Rastogi
et al.48 measured the FT-IR and FT-Raman spectra of 5-fluorouracil and made peak assignments
by comparing the experimental vibrational modes to those calculated using density functional
theory (B3LYP/6-31++G(3df,pd)). This study found that 5-fluorouracil only exists as the diketo
species in the solid state.
The neutral tautomers of 5-fluorouracil considered in this study are introduced in Figure
27. The relative energies of each tautomer as well as the associated solvation energies can be
found in Table 5. Calculations showed that FU-1 is significantly more stable than the other
tautomers in both vacuum and aqueous solution, despite the large solvation energy of FU-7.
Given the much higher energies of enolic species, it is unlikely that they significantly contribute
to the neutral population.

Figure 27: Neutral 5-fluorouracil tautomers.

The natural charges on the heavy atoms in FU-1 (Figure 28) are fairly consistent with
those observed in the other halogenated uracil derivatives. Again, the natural charge at N1 is less
negative than the natural charge at N3. However, in 5-fluorouracil C5 exhibits a positive charge
which should decrease the likelihood of protonation occurring at that position. There is a
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significantly more negative charge on the fluorine than observed on bromine or chlorine because
fluorine inductively withdraws more electron density through the σ-system.

Figure 28: Natural charges on the heavy atoms in FU-1.

5-fluorouracil also behaved as a carbon acid (Figure 29), in both vacuum and aqueous
solution, despite the slightly positive charge on C5. Again no reports of carbon acid behavior
were found in literature.

Figure 29: Low-energy cationic tautomers of 5-fluorouracil.

In vacuum and in aqueous solution N1H was determined to be the primary site of
dissociation. Again, quantum chemical calculations show that N1 carries a slightly more positive
charge than N3 (Figure 30). However, in aqueous solution FU--2 was only 6.1 kJ/mol higher in
energy (due to a large solvation energy) which indicates that it accounts for ~8% of the anionic
population. These results suggest that fluorinating C5 affects the anionic population ratios
slightly more than the other 5-halouracils. Again, Privat and Sowers suggest that fluorinating C5
should result in enhanced ionization of the N3 proton.36 Studies by Jang et al. indicate that 5-
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fluorouracil behaves much like uracil in that dissociation of N1 is favored in vacuum, but not in
solution.37

Figure 30: Low-energy anionic tautomers of 5-fluorouracil.

Table 5: Relative energies and solvation energies of 5-fluorouracil tautomers.
Neutral
FU-1
FU-2
FU-3
FU-4
FU-5
FU-6
Cationic
FU+-1
FU+-2
FU+-3
Anionic
FU--1
FU--2

Rel. E Vac. kJ/mol
0
38.3
47.6
52.6
107.6
116.5
Rel. E Vac. kJ/mol
0
27.1
30.7
Rel. E Vac. kJ/mol
0
51.2

Sol. Energy kJ/mol
-54.8
-59.3
-57.7
-71.6
-80.6
-120.5
Sol. Energy kJ/mol
-324.2
-310.7
-329.7
Sol. Energy kJ/mol
-261.2
-306.3

Rel. E Aq soln. kJ/mol
0
33.8
44.8
35.8
81.8
50.8
Rel. E Aq soln. kJ/mol
0
40.6
25.2
Rel. E Aq soln. kJ/mol
0
6.1

■ 5-Formyluracil
The 5-formyluracil tautomers considered in this study are shown in Figure 31. Jang et al.
has called attention to the presence of two low energy conformational isomers of 5-formyluracil.
They found that FlU-1 is 21.6 kJ/mol more favorable in vacuum, but expresses a 22.1 kJ/mol
lower solvation energy than FlU-2 leading to comparable energies in aqueous solution. In the
present study, FlU-1 was determined to be 22.8 kJ/mol more stable in vacuum than FlU-2, but
2.6 kJ/mol less favorable in solution due to a smaller solvation energy. A Boltzmann Distribution
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showed that in aqueous solution FlU-1 comprises ~26% of the neutral population with FlU-2
accounting for the remaining ~74% (Table 6). These results illustrate the importance of
considering conformers because they can be surprisingly different in energy. The other neutral
species were too high in energy to be significantly contributing tautomers. Conformers
associated with high energy species were not considered for energetic reasons.

Figure 31: Neutral 5-formyluracil tautomers.

The natural charges on the heavy atoms in FlU-1 were reported in Figure 32. Notice that
the natural charge at N1 is less negative than the natural charge at N3 despite the proximity of the
keto groups. The addition of a formyl group places a negative charge on C5 and positive charge
on C6. Also notice that the charges on the keto groups become more negative in aqueous
solution.

Figure 32: Natural charges on the heavy atoms in FlU-1.
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Despite steric crowding at C5, 5-formyluracil also behaved like a carbon acid. No
literature reports were found noting this preference for protonating C5, rather than a nitrogen, in
5-formyluracil. Yet in both vacuum and in aqueous solution FlU+-1 was determined to be the
most stable cationic species by ~40 kJ/mol and ~22 kJ/mol, respectively (Figure 33). The other
cationic species were considerably higher in energy which suggests that their populations will be
quite small.

Figure 33: Low-energy cationic tautomers of 5-formyluracil.

In vacuum FU--1was the most stable anionic form of 5-formyluracil by ~18 kJ/mol
(Figure 34). However, in aqueous solution a mixture of anionic species emerged with FlU--2
assuming ~36% of the population. While these results demonstrate a clear preference for
dissociation of N1H, they also show that the cis-conformation exhibits a much greater solvation
energy even when ionized. Studies by Jang et al. also cite N1 as the primary site of dissociation
because the formyl group stabilizes the N1 anion through resonance.37 This finding is further
supported by quantum chemical calculations that show a slightly more positive charge on N1
which is indicative of greater anionic stability (Figure 32).
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Figure 34: Low-energy anionic tautomers of 5-formyluracil.

Table 6: Relative energies and solvation energies of 5-formyluracil tautomers.
Neutral
FlU-1
FlU-2
FlU-3
FlU-4
FlU-5
FlU-6
FlU-7
FlU-8
Cationic
FlU+-1
FlU+-2
FlU+-3
FlU+-4
FlU+-5
Anionic
FlU--1
FlU--2
FlU--3
FlU--4

Rel. E Vac. kJ/mol
0
22.8
39.7
44.0
48.9
96.1
99.8
108.1
Rel. E Vac. kJ/mol
0
40.1
77.0
77.0
55.3
Rel. E Vac. kJ/mol
0
18.7
65.3
96.0

Sol. Energy kJ/mol
-60.7
-86.2
-66.7
-70.0
-99.9
-108.7
-97.7
-125.1
Sol. Energy kJ/mol
-316.7
-333.7
-363.5
-363.0
-335.2
Sol. Energy kJ/mol
-248.3
-256.6
-293.8
-328.5

Rel. E Aq soln. kJ/mol
2.59
0
36.2
37.3
12.3
50.8
65.4
46.3
Rel. E Aq soln. kJ/mol
0
23.1
30.6
30.2
36.8
Rel. E Aq soln. kJ/mol
0
1.41
19.8
15.9

■ 5-Nitrouracil
This study found that NU-1 was the predominant species in both vacuum and aqueous
solution (Table 7). The other neutral forms (Figure 35) were significantly higher in energy and
thus unlikely to exist in large quantities.
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Figure 35: Neutral 6-nitrouracil tautomers.

The natural charges on the heavy atoms in NU-1 are reported in Figure 36. Notice that
the natural charge at N1 is less negative than the natural charge at N3 as a result of the electron
withdrawing nitro group. The addition of a nitro group places a negative charge on C5 and a
positive charge on C6. Also notice that the charges on the keto groups become more negative in
aqueous solution.

Figure 36: Natural charges on the heavy atoms in NU-1.

As observed with each of the uracil derivatives, 5-nitrouracil showed a strong preference
for protonation at C5 which was previously unreported (Figure 37). In vacuum and in aqueous
solution

NU+-1was at least ~40 kJ/mol more favorable despite steric crowding at C5. The other

cationic species were much higher in energy which indicates that their formation is improbable.
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Figure 37: Low-energy cationic tautomers of 5-nitrouracil.

Calculations showed a strong preference for dissociation at N1H (Figure 38) in both
vacuum and in aqueous solution. Like a formyl group, a nitro group can stabilize N1- by
delocalizing charge through resonance which lends to the clear preference for dissociation at that
position.37 This finding is strengthened by quantum chemical calculations that show a slightly
more positive charge on N1 which is indicative of greater anionic stability (Figure 36). There is
no evidence that the dissociation of N3H is enhanced in aqueous solution, despite its slightly
larger solvation energy.

Figure 38: Low-energy anionic tautomers of 5-nitrouracil.

Table 7: Relative energies and solvation energies of 5-nitrouracil tautomers.
Neutral
NU-1
NU-2
NU-3
NU-4
NU-5
NU-6
NU-7
NU-8
Cationic
NU+-1

Rel. E Vac. kJ/mol
0
42.5
44.9
47.1
80.7
89.6
93.1
126.3
Rel. E Vac. kJ/mol
0

Sol. Energy kJ/mol
-67.0
-75.0
-74.8
-39.8
-68.8
-54.7
-110.4
-131.7
Sol. Energy kJ/mol
-324.5

Rel. E Aq soln. kJ/mol
0
78.8
34.5
37.1
49.7
102.0
74.3
61.5
Rel. E Aq soln. kJ/mol
0
39

NU+-2
NU+-3
Anionic
NU--1
NU--2

33.3
66.3
Rel. E Vac. kJ/mol
0
73.8

-334.5
-352.7
Sol. Energy kJ/mol
-238.9
-287.0

23.3
38.1
Rel. E Aq soln. kJ/mol
0
25.8

■ Thymine
X-ray crystallography studies by Voet et al.49 have found that thymine exists primarily as
a diketo species in the crystalline form. IR studies by Shugar et al. have also indicated that the
diketo species of thymine is the only significant tautomer. A theoretical study by Rejnek et al.50
investigated tautomerism in thymine using coupled cluster calculations CCSD(T) in both
vacuum and in bulk water using molecular dynamics. This study also found that the diketo
species was much more stable than any of the enolic forms. However, florescence studies by
Morsy et al. 51 have yielded evidence that trace amounts of enolic species may exist.
Figure 39 introduces the tautomers of thymine that were investigated in this study. The
relative energies of the tautomers as well as their solvation energies can be found in Table 8.
Calculations showed that T-1 (neutral diketo species) was the predominant tautomer in both
vacuum and aqueous solution. The other tautomers are significantly higher in energy which
indicates that they are unlikely to appear at significant concentrations. It is worth noting that in
some cases enolic species do exhibit greater solvation energies than the diketo species. However,
the diketo species remains lower in energy in aqueous solution, despite the large solvation
energies of the enolic species, because it is much more stable in the gas phase.
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Figure 39: Neutral thymine tautomers.

The natural charges on the heavy atoms in T-1 are reported in Figure 40. Notice that the
natural charge at N1 is less negative than the natural charge at N3 despite the proximity of the
keto groups. The addition of a methyl group places a negative charge on C5 and a positive charge
on C6. Also notice that the charges on the keto oxygens become more negative in aqueous
solution.

Figure 40: Natural charges on the heavy atoms in T-1.

In vacuum and in aqueous solution T+-1 was the only significantly populated cationic
form (Figure 41) of thymine. Again, literature has not reported carbon acid behavior in thymine
although the other cationic species were significantly higher in energy.
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Figure 41: Low-energy cationic tautomers of thymine.

In vacuum dissociation of the neutral species occurred primarily at N1H (Figure 42)
because T--1 was ~52 kJ/mol more stable than T--2. In aqueous solution calculations suggest a
mixture of T--1 (~96%) and T--2 (~4%) due to the large solvation energy of T--2. Quantum
chemical calculations showed that N1 carries a slightly more positive charge than N3 which also
supports a preference for dissociation at N1H (Figure 38). However, Jang et al. cite N3 as the
primary site of dissociation in thymine in both vacuum and aqueous solution.37.

Figure 42: Low-energy anionic tautomers of thymine.
Table 8: Relative energies and solvation energies of thymine tautomers.
Neutral
T-1
T-2
T-3
T-4
T-5
T-6
Cationic
T+-1
T+-2
T+-3
Anionic
T--1
T--2

Rel. E Vac. kJ/mol
0
79.0
80.5
81.7
85.8
96.8
Rel. E Vac. kJ/mol
0
33.4
40.9
Rel. E Vac. kJ/mol
0
52.8

Sol. Energy kJ/mol
-53.3
-86.9
-69.3
-79.0
-101.4
-89.1
Sol. Energy kJ/mol
-303.3
-277.7
-300.9
Sol. Energy kJ/mol
-284.2
-329.2

Rel. E Aq soln. kJ/mol
0
45.4
64.5
55.5
37.6
61.0
Rel. E Aq soln. kJ/mol
0
59.0
43.4
Rel. E Aq soln. kJ/mol
0
7.8
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Chapter 3
Analysis of Cytosine Tautomers

3.1 An introduction to cytosine
The properties of cytosine are of fundamental biological and chemical importance.40
Understanding the chemical behavior of cytosine can provide insight into the relationship
between the presence of rare tautomeric forms and spontaneous point mutations.52 Normal
Watson-Crick base pairing occurs between the canonical forms of pyrimidine nucleobases and
their complimentary purines with the appropriate orientations.53 However, rare tautomers can
form mutagenic base pairs by achieving an appropriate orientation with an incorrect purine.53 As
a result the population ratios of parent nucleobases and their minor tautomeric forms have
received much investigation. Unlike uracil, where a single (neutral diketo) species dominates,
several low energy tautomers of cytosine are observed.52 As a result, there has been much debate
as to which cytosine forms are predominant in a given medium.

3.2 Methods
The methods used for tautomer analysis have been described in detail in Chapter 2:
Analysis of Uracil Tautomers. In this chapter attention is turned to the analysis of cytosine
tautomers by employing the same protocol.

3.3 Results

■ Cytosine
An early theoretical paper53 by Katritzky and Karelson used AM1 computations coupled
with a self-consistent reaction field solvent model to estimate the relative stabilities of cytosine
tautomers. While this study was insightful, it neglected to investigate the impact of conformers
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associated with low-energy tautomeric forms. Matrix isolation infrared studies have identified
the presence of cytosine tautomers C-1, C-2 and C-4, (see below) with the hydroxy-amino (C-2)
form having the highest concentration.54 Computational studies by Fogarasi55 and Kobayashi56
have reported slight differences in the hierarchy of stability that are largely method-dependent.
Fogarasi calculated the relative energies of cytosine tautomers using single point coupled cluster
single and double (CCSD) energies at MP2 optimized geometries with double-zeta basis sets and
reported that the order of energies was C-2 > C-4 > C-1. In contrast, Kobayashi calculated the
relative energies of cytosine tautomers using density functional theory at the B3LYP/6-31+G
level and reported that the order of stability was C-2 > C-1 > C-4.
A recent study by Alonso et al.52 has identified the presence of five distinct forms of
cytosine in the gas phase using LA-MB-FTMW spectroscopy. This study was one of the first to
demonstrate the capability to not only distinguish tautomeric forms but also conformers.
However, this study did not investigate the impact of solvation on the population ratio of the
tautomers and conformers of cytosine. The present study aims to assess the impact of solvation
upon low-energy tautomers/conformers.
The structures of the neutral cytosine tautomers/conformers considered are shown in
Figure 43. Notice that the enolic protons are oriented towards the lone pair on the adjacent
nitrogen due to electrostatic attraction. The present calculations (Table 9) show that several
neutral species exist in vacuum with C-1 in the highest concentration (~58%). Minor contributors
included C-2 (~31%), C-3 (~8%) and C-4 (~3%). Calculations suggested a clear preference for
C-1 in aqueous solution due to its large solvation energy. The electrostatic potential maps
(Figure 44) show that C-1 has a much more uneven charge distribution than C-2 which explains
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its larger solution energy. The other neutral species were significantly higher in energy which
indicates that they are unlikely to exist in significant quantities.

Figure 43: Neutral cytosine tautomers.

C-2
C-1
Figure 44: Molecular electrostatic potential maps of C-1 and C-2.

Regarding the cationic tautomers of cytosine the present calculations predict a mixture of
C+-1 (~62%) and C+-3 (~38%) in vacuum because C+-1 is just 1.5 kJ/mol lower in energy than
C+-3 (Figure 45). In aqueous solution favorability shifts towards C+-3 because it has a larger
solvation energy than C+-1. The other cationic species were much higher in energy which
suggests that they are unlikely to exist in significant quantities. Notice that in the lowest-energy
conformations enolic protons are oriented away from protonated imines due to electrostatic
repulsions. Figure 46 shows the single dominant anionic form of cytosine.

45

Figure 45: Low-energy cationic tautomers of cytosine.

Figure 46: Dominant anionic form of cytosine.

Table 9: Relative energies and solvation energies of cytosine tautomers.
Neutral
C-1
C-2
C-3
C-4
C-5
C-6
C-7
C-8
Cationic
C+-1
C+-2
C+-3

Rel. E. kJ/mol (Vac.)
0
1.60
4.85
7.70
15.5
29.2
56.7
78.3
Rel. E. kJ/mol (Vac.)
0
36.7
1.5

Solv. E. kJ/mol
-91.0
-69.9
-71.5
-55.3
-53.6
-99.4
-54.7
-73.2
Solv. E. kJ/mol
-263.5
-274.3
-286.3

Rel. E. kJ/mol (Aq. Soln)
0
92.6
24.3
43.4
52.9
20.9
93.0
96.1
Rel. E. kJ/mol (Aq. Soln)
21.4
47.2
0

■ Flucytosine
In flucytosine a fluorine atom is substituted on carbon 5. As observed in cytosine, several
low-energy tautomers (Figure 47) of flucytosine were present in vacuum (Table 10). The
majority of the population consisted of FC-1 (~76%) but small quantities of FC-2 (~17%) and
FC-3 (~7%) were also estimated to be present. In aqueous solution the neutral population was
composed predominantly of FC-3 because it exhibits a much greater solvation energy than the
other forms. Figure 48 shows the electrostatic potential maps of FC-1 (most stable form in
46

vacuum) and FC-3 (most stable form in water). As expected the electrostatic potential map of
FC-3 displays a more uneven charge distribution than FC-1 which is indicative of a greater
solvation energy.

Figure 47: Neutral flucytosine tautomers.

FC-3
FC-1
Figure 48: Molecular electrostatic potential maps of FC-1 and FC-3.

A Boltzmann Distribution showed that FC+-1 was the only significant protonated species
of flucytosine in vacuum (Figure 49). In aqueous solution there was a strong shift towards FC+-3
but miniscule amounts of FC+-1 (~2%) may still be present. The formation of FC+-4 is extremely
unlikely because protonating N1 severely distorts the planarity of the ring. Figure 50 shows the
dominant anionic form of flucytosine.
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Figure 49: Low-energy cationic tautomers of flucytosine.

Figure 50: Dominant anionic form of flucytosine.

Table 10: Relative energies and solvation energies of flucytosine tautomers.
Neutral
FC-1
FC-2
FC-3
FC-4
FC-5
FC-6
FC-7
Cationic
+

FC -1
FC+-2
FC+-3

Rel. E. kJ/mol (Vac.)
0
3.73
5.54
14.4
38.7
55.8
85.8
Rel. E. kJ/mol (Vac.)
0
37.9
11.47

Solv. E. kJ/mol
-58.8
-70.0
-76.1
-47.6
-87.2
-50.3
-73.3
Solv. E. kJ/mol
-264.7
-276.8
-285.8

Rel. E. kJ/mol (Aq. Soln)
11.2
12.8
0
36.8
21.6
75.4
82.5
Rel. E. kJ/mol (Aq. Soln)
9.67
35.4
0

■ Isocytosine
In vacuum a mixture of IC-1 (~91%) and IC-2 (~9%) were calculated to be present
(Figure 51, Table 11). An experimental study reported that in vacuum isocytosine primarily
exists as IC-1, but suggests that low concentrations of IC-2 may be present.57 Calculations
showed that in aqueous solution the majority of the population is IC-5 (~60%) with smaller
contributions from IC-2 (~38%) and IC-1 (~2%). Figure 52 shows the electrostatic potential
maps of IC-1 and IC-5. Solvent molecules can more easily form local associations with IC-5 than
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with IC-1 because it exhibits a more uneven charge distribution. Thus the relative stability of IC5 is enhanced in aqueous solution.

Figure 51: Neutral isocytosine tautomers.

IC-1

IC-5

Figure 52: Molecular electrostatic potential maps of IC-1 and IC-5.

In vacuum the cationic population were estimated to consist of a mixture of IC+-1 (~70%)
and IC+-3 (~30%) due to an energy difference of just ~3 kJ/mol (Figure 53). However, in
aqueous solution IC+-3 is the predominant tautomer because it had a much greater solvation
energy. Figure 54 shows the sole dominant anionic form of isocytosine.
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Figure 53: Low-energy cationic tautomers of isocytosine.

Figure 54: Dominant anionic form of isocytosine.
Table 11: Relative energies and solvation energies of isocytosine tautomers.
Neutral
IC-1
IC-2
IC-3
IC-4
IC-5
IC-6
IC-7
Cationic (2a-4e-IC)
IC+-1
IC+-2
IC+-3

Rel. E. kJ/mol (Vac.)
0
5.34
19.7
30.6
48.3
91.1
130.5
Rel. E. kJ/mol (Vac.)
0
12.6
2.19

Solv. E. kJ/mol
-52.2
-65.1
-65.4
-54.0
-109.2
-79.4
-83.0
Solv. E. kJ/mol
-282.7
-268.9
-306.8

Rel. E. kJ/mol (Aq. Soln)
8.65
1.14
15.2
37.4
0
72.6
108.4
Rel. E. kJ/mol (Aq. Soln)
13.8
40.4
0
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Chapter 4
Theoretical Estimation of pKa’s

4.1 An introduction to pKa’s and the value of computational estimation
Acid dissociation constants are important because they identify the most stable chemical
species of a compound at a particular pH. Determining the dominant chemical species is useful
because molecular characteristics can be used to predict chemical behavior. Computationally
estimating pKa’s is valuable because it circumvents many of the difficulties presented by
experimental measurement of pKa’s.1 The pKa for dissociation of the cationic species of a
compound to form the neutral species is defined as pKa1, and that for the dissociation of the
neutral species to form the anion is defined as pKa2 (Eq. 1). The acid dissociation constant Ka
refers to the ratio of the proton dissociation products to that of the acid reactant (Eq. 2). The Ka
can be used to determine the pKa of dissociation using Eq. 3. The change in Gibbs free energy at
equilibrium ΔG˚ is related to the Ka and pKa by Eq. 4.
(1)

Ka =

[𝐀− ][𝐇+ ]

(2)

[𝐀𝐇]
[𝑨− ]

pKa = -log10 (Ka) = pH + log [𝐇𝐀]

(3)

ΔE ≈ ΔG˚ = 2.303 RT pKa

(4)

A compound’s acidity (pKa) is dependent upon the stability of its conjugate base because
dissociation is more likely to occur if the resultant anion is stable. Increasing the stability of the
conjugate base increases the acidity of the conjugate acid (lowers pKa). Likewise, decreasing the
stability of the conjugate base will decrease the acidity of the conjugate acid (raises pKa). Figure
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55 shows the conjugate acid-base pairs of aziridine for both the cationic to neutral dissociation
(pKa1) and the neutral to anionic dissociation (pKa2). A compound’s acidity can be influenced by
several factors that will be discussed in the subsequent paragraphs.

Figure 55: Conjugate acid-base pairs of aziridine associated with pKa1 and pKa2.

Inductive effects can influence acidity by modifying the electron density at the site of
dissociation through the σ-framework. Electron withdrawing substituents tend to decrease pKa by
diminishing electron density at the dissociation site, while electron donating groups increase pKa
by increasing electron density at the dissociation site.
Resonance also plays a key role in acidity by providing a mechanism for charge
delocalization through the π-system. The magnitude of the.
resonance effect is generally proportional to the number of resonance structures that a
compound can adopt. Compounds that have many resonance structures are generally more stable
than compounds that have few or no resonance structures. For example, unsaturated compounds
that resonate will generally exhibit lower pKa’s than their saturated analogs because electron
density can be delocalized about the π-system. Aromatic compounds are especially stable
because conjugated π-electron systems efficiently delocalize charge throughout the molecule.
Hyperconjugation is a distinct type of resonance that arises from alkyl moieties such as methyl
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groups. Methyl groups are sp3 hybridized which gives rise to three-dimensional interactions
involving the π system. The out-of-plane component of these sigma bonds donates electron
density to the π-electron system through hyperconjugation which results in increased basicity.
Theoretical pKa values can be calculated using a variety methods. The first principles
approach uses thermodynamic cycles because they offer an energetic pathway from the reactants
to the final products and include thermodynamic state functions.1 The first principles approach is
useful because it is independent of associated experimental data, such as the pKa’s of related
compounds.1 However, it is very computationally demanding and dependent on accurate solvent
models, and is therefore often impractical.1 Advanced Chemical Development, Inc. (ACD) has
also developed a method for computationally estimating pKa’s. ACD employs a fragment based
approach to estimating pKa’s in which segments of compounds are assigned Hammett constants.
The fragments and their corresponding Hammett constants are then compiled to form a database.
A pKa can then be estimated for any compound that contains fragments reported in the database.
However, this method can be problematic if the database is not coded for a fragment contained in
the compound of interest.
Quantitative Structure-Activity Relationships (QSARs) are a widely applicable modeling
method that can be adapted to estimate pKa’s. This study will use QSAR modeling to estimate
the pKa’s of important compounds that are not currently reported in the literature. To do this,
quantum chemical calculations are first performed and useful molecular descriptors Xi are
identified. Molecular descriptors are features that correlate with the propensity of a molecule to
undergo some behavior, in this case to dissociate at a particular pH. In a group of related
compounds, molecular features are expected to alter the Gibbs free energy G˚ of a compound in
a consistent fashion. The merit of each molecular descriptor is determined through a linear
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regression analysis, which correlates Xi with variations in the experimentally observed pKa’s
(Eq. 5, where Ci is the coefficient of Xi).
pKa = Co + C1X1 + C2X2 + C3X3 + ….

(5)

While QSAR modeling does rely on the compilation of experimental data, such as pKa’s, it
requires significantly less computational effort than the aforementioned first principles
methodology.

4.2 Methods
Experimental pKa’s were collected from literature sources for each compound. However,
experimental pKa’s were unavailable for several of the compounds. These pKa’s will be
estimated in this study. Additionally, pKa’s calculated by Advanced Chemical Development’s
commercial program were determined for comparison purposes. Experimentally determined
ΔG’s (for dissociation of the neutral species) were obtained from the NIST database58 for 6
compounds.
The following calculations were repeated for the most stable tautomer of each charge (as
determined in Chapters 2 and 3) in vacuum and in aqueous solution. Quantum chemical
calculations were performed using the Spartan’10 computational software package (Wavefunction, Inc., Irvine, CA) with and without the SM8 aqueous solution model.4 A rough
equilibrium geometry of each compound was first obtained using the RM1 semiempirical
method.11 The equilibrium geometry of each compound was then further optimized using density
functional theory at the B3LYP/ 6-31+G** level. A series of quantum chemical descriptors was
selected that included natural charges, Löwdin bond lengths, bond orders and the energy
difference (ΔE) between the dissociating acid species and its dissociated species. The ΔE’s
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associated with the dissociation reactions of pKa1 and pKa2 were examined in both vacuum and in
aqueous solution.
A linear regression analysis was performed on each correlation to ensure statistical
soundness. The statistics examined included the correlation coefficient R, the coefficient of
determination R2, the standard deviation s, and the Fisher Statistic F. The correlation coefficient
R indicates the extent to which variations in experimental pKa values and the targeted molecular
descriptor Xi coincide. The correlation coefficient ranges from -1 to 1, where the highest and
lowest values are the most statistically significant.1 The coefficient of determination R2 indicates
the fraction of the variance in the experimental pKa’s that is accounted for by the linear free
energy relationship (LFER) equation.1 The coefficient of determination ranges from 0 to 1,
where 1 would indicate a perfect correspondence. The standard deviation is a measure of the
average uncertainty in the calculated pKa and should be as small as possible. The Fisher Statistic
gives a measure of how well the model performs for a given number of descriptors.1 The Fisher
Statistic should be as large as possible with the fewest number of descriptors possible used in the
linear regression model.

4.3 Results

■ Literature compilation
Table 12 shows the compounds selected for this study, their chemical formulas,
experimentally measured pKa1/pKa2 values and ACD-calculated pKa1/pKa2 values. Compounds
for which pKa’s are currently unreported are indicated by a dash. The pKa’s of these compounds
will be estimated in this study. N/A indicates compounds for which a nitrogen acid pKa does not
apply. Note that pyrrole and uracil and its derivatives were found to act as carbon acids (pKa1) so
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they were excluded from the pKa regressions because carbon acids are not expected to behave in
the same way as nitrogen acids.
Table 12: pKa1 and pKa2 values of pyrimidines and related heterocycles.
#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Compound
azauracil
aziridine
creatinine
cytosine
flucytosine
imidazole
1-methylimidazole
4-methylimidazole
isocytosine
isoxazole
maleimide
morpholine
piperidine
piperazine
1-methylpiperazine
oxazole
pyrazine
pyrazole
pyridazine
pyridine
pyrimidine
pyrrole
pyrrolidine
succinimide
thymine
uracil
5-bromouracil
5-chlorouracil
fluorouracil
5-formyluracil
5-nitrouracil

Formula
C3H3N3O2
C2H5N
C4H7N3O
C4H5N3O
C4H3FN2O2
C3H4N2
C4H6N2
C4H6N2
C4H5N3O
C3H6NO
C4H3NO2
C4H9NO
C5H11N
C4H10N2
C5H12N2
C3H6NO
C4H4N2
C3H4N2
C4H4N2
C5H5N
C4H4N2
C4H5N
C4H9N
C4H5NO2
C5H6N2O2
C4H4N2O2
C4H3BrN2O2
C4H3CIN2O2
C4H4FN3O
C5H4N2O3
C4H3N3O4

pKa1
7.9859, 8.0560
4.861
4.3260, 4.5862, 4.661
3.2661
7.1560, 6.99361-62
6.9561
7.5562
4.0161
-2.061
8.49262
11.1262
9.7862, 9.7361
10.1962
0.861
0.6561
2.6162
2.359
5.2361
1.359
-3.861
12.1060, 11.3161-62
-

ACD pKa1
-4.4± 0.2
8.1 ± 0.2
4.8 ± 0.1
4.4 ± 0.1
2.6 ± 0.1
7.2 ± 0.6
7.0 ± 0.1
7.7 ± 0.6
3.4 ± 0.5
-2.0 ± 0.5
-5.7 ± 0.2
9.0 ± 0.2
10.4 ± 0.1
9.6 ± 0.1
9.3 ± 0.1
1.0 ± 0.1
1.2 ± 0.1
2.8 ± 0.1
3.1 ± 0.1
5.2 ± 0.1
1.8 ± 0.1
-0.3 ± 0.5
10.5 ± 0.1
-4.4 ± 0.2
-4.1 ± 0.4
-4.2 ± 0.1
-

pKa2
1360, 12.1562-63
14.4460
N/A
9.4263
N/A
9.564
N/A
N/A
N/A
14.2160
N/A
N/A
N/A
17.060
9.6261-62, 9.6863
9.960, 9.7962, 9.4461
9.4336, 9.4561, 63
7.9136
7.9236
8.0460, 8.0065, 7.9336
6.8436
5.336

ACD pKa2
7.8 ± 0.2
12.3 ± 0.1
10.5 ± 0.1
13.9 ± 0.1
14.3 ± 0.1
9.6 ± 0.4
8.5 ± 0.2
14.0 ± 0.5
17.0 ± 0.5
9.6 ± 0.1
9.2 ± 0.1
8.9 ± 0.1
6.8 ± 0.1
6.8 ± 0.1
6.7 ± 0.1
7.3 ± 0.1
5.2 ± 0.1
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■ An investigation of the adequacy of the B3LYP/6-311+G** model.
Equations 7 and 8 below show the Gibbs Energy associated with the dissociation of a
neutral species (pKa2). However, the G difference between the neutral acid (HA) and anion (A-)
does not account for the ΔG of the mole of dissociated protons (H+). Accordingly, the ΔG of a
mole of dissociating protons was determined to be 23.6 kJ/mol through a derivation that is shown
in the appendix of this chapter. Note that NIST only lists experimentally measured ΔG’s for six of
the compounds included in this study (Table 13).
ΔG° = G°products – G°reactants

(7)

ΔG° = (G°anion + G°proton) – G°neutral

(8)

Table 13: Experimental and calculated ΔG’s.
Exp. ΔG° a

Calc. ΔG° b

Calc. ΔE b

pyridine

-1601.0

-1631.9

-1647.9

pyridine

-1604.6

-1631.4

-1642.5

pyrazine

-1576.5

-1604.8

-1613.8

pyridazine

-1562.0

-1588.0

-1600.9

imidazole

-1433.4

-1458.4

-1466.2

succinimide

-1414.0

-1426.9

-1436.4

Compound

a

From the NIST database58
b
B3LYP/6-31+G**
The correlation between experimentally measured vacuum ΔGs and theoretically
calculated ΔGs for the dissociation reactions (Figure 56) was examined to evaluate the merit of
the B3LYP/6-31+G** computational level, and the following correlation was obtained:
ΔGrxn (exp.) = 0.94 (± 0.02) ·∆Grxn (calc.) – 64 (± 34)

(9)

n = 6, r2 = 0.998, s = 4.18 kJ/mol, F = 2344
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Correlation of the calculated vacuum Gibbs Energies with the experimental results yielded a
standard deviation of s = 4.18 kJ/mol, a value close to the average experimental uncertainty. In
addition, the Fisher statistic (F = 2344) was high, which indicates a good computational model.
The coefficient of determination was exceptionally high (R2 = 0.998), indicating that the vacuum
quantum chemical calculations closely correlated with the experimental measurements. The
linear regression analysis verified that this level of computation is more than adequate to
reproduce experimental data.

Experimental ΔG°'s kJ/mol

Experimental ΔG°'s vs. Theoretical ΔG°vac's
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Figure 56: Plot of experimentally measured ΔG°’s vs. theoretically calculated ΔG°vac’s for pKa2.

■ Why is ΔE a good quantum chemical descriptor for pKa?
The ΔG° cannot be calculated in aqueous solution because solute-solvent interactions
prevent the calculation of vibrations and rotations. Identifying a ΔG° surrogate that can be
calculated in aqueous solution would prove to be a computational asset. Substituting ΔE for ΔG°
is a common practice because ΔE can be more easily calculated. In addition, ΔE can be
calculated using a solvent model like SM8 that can correct for solvation energy. The ΔE is often
used as an approximation of ΔG° which is related to pKa by Equation 10.
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ΔE ≈ ΔG˚ = 2.303 RT pKa

(10)

Experimentally measured ΔG°’s associated with the dissociation of a neutral species to form an
anionic species and a proton were collected from NIST58 and compared to theoretically
calculated ΔE’s (Table 13) and the following linear regression is shown in equation 11.
ΔEpKa2 (calc.) = 1.08(± 0.02) · ΔG°pKa2 + 88 (± 37)

(11)

n = 6, r2 = 0.999, s = 3.47 kJ/mol, F = 3021
Experimentally measured ΔG°’s showed an excellent correlation (R2= 0.999) with theoretically
calculated ΔE’s (Figure 57). In addition, the fisher statistic was extremely high (F=3021) and the
standard deviation (s = 3.47 kJ/mol) was relatively low.
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Figure 57: Plot of theoretical ΔEvac’s vs. experimental ΔG°’s for pKa2.

These results indicate that ΔE is a suitable substitute for ΔG° which significantly
simplifies the theoretical estimation of pKa’s. Although the model was only tested in vacuum it is
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reasonable to expect that ΔE would also be a valid surrogate for ΔG° in conjunction with a
solvent model.
It was of interest to see if the vacuum E values for the dissociations could be used to
approximate the solution pKa’s. Accordingly, linear regressions (Figures 58 and 59) were
constructed using experimentally measured aqueous pKa’s and theoretically calculated ΔEvac’s
for pKa1 and pKa2. The regression equations and the related statistics for pKa1 and pKa are shown
in equations 12 and 13, respectively:
pKa1 (calc.) = – 0.08 (± 0.01) ·∆Evac – 66 (± 11)
n = 20, R2 = 0.707, s = 2.18 F = 43.6

(12)

pKa2 (calc.) = – 0.0592 (± 0.007) ·∆EAq – 75 (± 10)
n = 13, R2 = 0.874, s = 1.17 F = 76.8

(13)

The correlations obtained were only modest because the ΔE of the isolated molecules
does not account for the role of the solvent in affecting the pKa’s in water. The experimentally
determined aqueous pKa’s are affected by solute-solvent interactions that need to be accounted
for by using a solution model. Other quantum chemical descriptors such as charges, bond lengths
and bond orders did not correlate well with the experimental pKa’s.
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Experimental pKa1's
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Figure 58: Plot of experimental pKa1’s vs. theoretical ΔEvac’s.
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Figure 59: Plot of experimental pKa2’s vs. theoretical ΔEvac’s.

■ Employing the SM8 aqueous solution model to account for the solvation energy
The quantum chemical calculations were repeated using the SM8 solvent model4 in an
effort to obtain a better correlation with experimental pKa’s by accounting for solvent effects on
the pKa’s. The SM8 solvent model accounts for solvation energy by employing a dielectric field
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to implicitly model solute-solvent interactions. A linear regression (Figure 60) was constructed
using the ΔEAq for the dissociation of the cation to the neutral species plus a proton and
experimentally measured pKa1’s. This resulted in a considerably improved coefficient of
determination (R2= 0.965). The linear regression and related statistics are shown in equation 14.
pKa1 (calc.) = – 0.131 (± 0.008) ·∆EAq – 151 (± 10)
n = 18, R2 = 0.965, s = 1.25, F = 145

(14)

The merit of this computational model was further corroborated by a good Fisher statistic
(F= 145) and relatively low standard error (s = 1.25). This suggests that the SM8 solvent model
corrects for a large portion of the error observed in the vacuum model by accounting for
solvation energy.
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Figure 60: Plot of experimental pKa1’s vs. theoretical ΔEaq’s.
A linear regression (Figure 61) was also constructed to model the relationship between
ΔEAq for dissociation of a neutral species and the experimentally measured pKa2’s, and the
following linear regression and related statistics are shown in equation 15.
pKa2 (calc.) = – 0.141 (± 0.008) ·∆EAq – 159 (± 10)

(15)
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n = 14, R2 = 0.962, s = 0.612, F = 304
Again, the addition of the SM8 solvent model increased the coefficient of determination (R2 =
0.962) significantly. The Fisher statistic is significantly larger here (F = 304) than observed in
the model of pKa1 (F = 145) despite both models containing just one descriptor. In addition, a
significant decrease in the standard deviation of the model was observed (s = 0.612). Statistical
differences between these two models may be due to the uncertainty of experimental pKa1’s.
Experimental pKa2’s may contain less uncertainty than pKa1’s because they are more widely
studied due to their biological relevance.
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Figure 61: Plot of experimental pKa2’s vs. theoretical ΔEaq’s.
These statistics indicated that ΔEAq is a very reliable molecular descriptor of experimental
pKa’s. The pKa’s of similar heterocycles can most likely be accurately predicted using these
computational models.

■ An examination of Advanced Chemical Development’s pKa models
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As previously noted, the commercial program ACD employs a method that can be used
to estimate a compound’s pKa. The merits of the ACD calculated pKa’s were assessed in the
interest of further testing the computational models designed in this thesis. A linear regression
was constructed to model the relationship between experimentally measured pKa1’s and ACD
calculated pKa1’s (Figure 62) and the following linear regression and related statistics are shown
in equation 16.
Pka1 (EXP.) = 1.07 (± 0.03) · Pka1 (ACD) + 0.34 (±0.2)
n = 19, R2 = 0.991, s = 0.334, F = 1583

(16)

The correlation was large (R2 = 0.991) which indicates that the ACD computational model yields
good results. The quality of this computational model was validated by the large Fisher statistic
(F = 1583) and low standard deviation (s = 0.334).
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Figure 62: Plot of Experimental pKa1’s vs. ACD calc. pKa1’s.
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A linear regression was also constructed to model the correlation between experimentally
measured pKa2’s and ACD calculated pKa2’s (Figure 63) and the following linear regression and
related statistics were obtained (equation 17):
pKa2 (exp) = 0.95 (± 0.05) · pKa1 (ACD) + 0.92 (±0.52)

(17)

n = 13, R2 = 0.966, s = 0.612, F = 316
This model also yielded a high correlation coefficient (r2 = 0.996), the standard deviation of this
model remained low (s = 0.612), but the Fisher statistic (F = 316) decreased significantly. These
results suggest that ACD calculated pKa1’s have a slightly higher correlation with experimental
pKa’s. This was an interesting finding because the computational models designed in this thesis
correlated slightly better with experimentally determined pKa2’s.
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Figure 63: Plot of experimental pKa2’s vs. ACD calculated pKa2's.

These results indicate that ACD calculated pKa’s are of comparable quality to those
calculated by the theoretical models designed in this thesis. However, ACD calculated pKa’s are
limited to compounds that contain only fragmented segments found in the company database.
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Additionally, this study revealed that ACD calculated pKa’s only consider nitrogen acids while
excluding other types, such as carbon acids. ACD also fails to identify the major tautomer,
although they do list multiple tautomeric forms associated with a compound.

■ Estimating pKa’s of compounds with previously unreported pKa’s
The pKa’s of compounds for which there was no previously reported literature value were
estimated using the computational models developed in this study (Tables 14 and 15). The
literature values shown in Tables 14 and 15 are averaged (when applicable) values taken from
Table 12 and used in the linear regressions. The pKa1’s of uracil and its derivatives and also
pyrrole were not estimated because calculations shown in Chapter 2 revealed that they act as
carbon acids, and therefore their values would require a unique computational model. Oxazole
and isoxazole were determined to be pKa1 outliers and were therefore omitted from the
regression. The calculated pKa1’s for these two compounds are extremely negative, which may
explain why they were outliers. For one thing, negative pKa’s can be difficult to measure. The
estimated pKa2’s in this study appear to fall within reasonable ranges given the structures of the
associated compounds.

66

Table 14: Literature pKa1’s and estimated pKa1’s.
Compound
azauracil
aziridine
creatinine
cytosine
flucytosine
imidazole
1-methylimidazole
4-methylimidazole
isocytosine
isoxazole
maleimide
oxazole
piperidine
piperazine
1-methylpiperazine
pyrazine
pyrazole
pyridazine
pyridine
pyrimidine
pyrrolidine
succinimide
a

ΔE kJ/mol
-1084
-1216
-1188
-1183
-1169
-1213
-1216
-1215
-1183
-1115
-1035
-872
-1239
-1226
-1231
-1166
-1174
-1186
-1200
-1172
-1239
-1007

Exp. pKa1
8.01
4.8
4.5
3.26
7.07
7.95
7.55
4.01
-2.0
0.8
11.12
9.76
10.19
0.65
2.61
2.3
5.23
1.3
11.71
-

Est. pKa1a
-9.38
7.98
4.21
3.50
1.80
7.44
7.85
7.65
3.55
-4.85
-15.81
-7.92
10.93
9.17
9.84
1.38
2.49
3.10
5.82
2.15
10.90
-19.51

Residuals
0.433
0.019
0.071
-0.062
-0.123
-0.299
0.198
-0.274
1.32
1.31
0.277
-2.02
-0.939
-1.46
-0.751
-1.94
1.49
-

pKa1’s were estimated using equation 14.
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Table 15: Literature pK2’s and estimated pKa2’s.
Compound
azauracil
aziridine
creatinine
cytosine
isocytosine
flucytosine
imidazole
4-methylimidazole
maleimide
piperazine
1-methylpiperazine
piperidine
pyrrole
pyrrolidine
thymine
uracil
5-bromouracil
5-chlorouracil
fluorouracil
5-formyluracil
5-nitrouracil
b

ΔE kJ/mol
-1179
-1325
-1217
-1216
-1196
-1910
-1216
-1224
-1196
-1313
-1395
-1310
-1243
-1390
-1199
-1200
-1184
-1182
-1193
-1180
-1159

Exp. pKa2
12.57
9.42
14.4
9.5
17.0
9.71
9.44
7.91
7.92
7.99
6.84
5.3

Calc. pKa2b
7.31
28.97
12.67
12.39
9.61
11.70
12.40
13.77
9.63
34.67
37.69
38.43
16.16
37.04
10.05
10.18
7.83
7.56
9.15
7.35
4.33

Residuals
0.665
0.0189
-0.224
-0.148
-0.159
0.803
-0.391
-0.770
0.0463
0.328
-1.03
-0.546
0.935

pKa2’s were estimated using equation 15.
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4.4 Appendix
Below is the derivation of the Gibbs Energy of a mole of protons. This derivation was
performed because Spartan’10 does not account for the Gibbs Energy of a proton. The molar
Gibbs Energy was added to the theoretically calculated ΔG’s in order to achieve a more
complete theoretical model. The derivation begins with the Gibbs Energy definition:
𝐺 𝑜 = 𝐻 𝑜 − 𝑇𝑆 𝑜

(1)

The enthalpy H is equal to the sum of the internal energy and the product of the pressure and
volume.
𝐻 𝑜 = 𝑈 + 𝑃𝑉

(2)

The product of pressure and volume can be estimated from the ideal gas law, where the number
of moles is equal to one.
𝑃𝑉 = 𝑛𝑅𝑇, 𝑛 = 1

(3)

The internal energy can be determined from the translational energy expression from the law of
equipartition of energy for three degrees of motional freedom:
3

𝑈 = 2 (𝑅𝑇)

(4)

3

The enthalpy can be calculated by substituting PV = RT and the internal energy U = 2 (𝑅𝑇) into
Eq. (2):
3

5

𝐻 𝑜 = 2 (𝑅𝑇) + 𝑅𝑇 = 2 (𝑅𝑇)

(5)

The entropy S of a mole of protons can be calculated using the Sakur-Tetrode equation.
𝑘𝐽

𝑆 𝑜 = 1.5𝑅 𝑙𝑛(𝑀) + 2.5𝑅 ln(𝑇) − 1.1517𝑅 = 0.1089 𝑚𝑜𝑙∗𝐾
5

𝑘𝐽

𝑘𝐽

𝐺 𝑜 = 2 𝑅𝑇 − 𝑇 (0.1089 𝑚𝑜𝑙∗𝐾) ≈ −26.3 𝑚𝑜𝑙

(6)

(7)

The Gibbs Energy of a mole of protons is therefore approximately -26.3 kJ/mol at T = 298 K.
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